5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
5+ ITEMS = 10% OFF
EU WAREHOUSE · 24–48H DELIVERY
PLAIN BOX · ZERO BRANDING
PAY THE COURIER · NO CARD NEEDED
FREE SHIPPING OVER €85
Try a substance, brand, or product name…
Cart 0
€85,00 more for free shipping
No products in the cart.
Injectable Steroids
Parabolan (Tren Acetate) 100mg
Parabolan (Tren Acetate) 100mg (100 mg) — Precision-dosed by Rotterdam for consistent results, this Trenbolone blend combines multiple esters (typically Acetate, Enanthate,...
€45,00
In Stock(100 available)
Rotterdam · Parabolan (Tren Acetate) 100mg (100 mg) — Precision-dosed by Rotterdam for consistent results, this Trenbolone blend combines multiple esters (typically Acetate, Enanthate,…
100 in stock
5+−10%
10+−15%Best price
Third-Party Lab ReportHPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
This the manufacturer tren E at 100 mg delivers trenbolone’s full mechanism (5× androgen-receptor affinity, glucocorticoid binding, nutrient partitioning) with a longer release profile than acetate. Pair with testosterone at TRT dose minimum.
Key Benefits
Most potent AR agonist in common use — ~5× testosterone affinity
No aromatisation — zero oestrogen conversion, no water retention
Dramatic nutrient-partitioning — recomp on maintenance calories
Short ester — fast onset, fast exit, EOD pinning minimum
Each unit dosed at 100 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 50–100 mg every other day (150–350 mg/week effective). First-time tren users start at 50 mg EOD for 2 weeks to gauge tolerance. Cycles 8–10 weeks — the compound does not reward longer runs.
How It Works
19-nor derivative with C9 and C11 double-bond additions conferring extreme androgen-receptor affinity. Does not aromatise. Moderately progestagenic — raises prolactin in some users. Potent nutrient-partitioning effect: simultaneous lean-mass accrual and fat loss at maintenance calories.
Pharmacokinetics
Plasma half-life approximately 1 day (acetate ester). EOD minimum pinning; daily smoother. Rapid onset within days, rapid clearance (2 weeks). Short cycle tail makes PCT timing straightforward: start 3 days post-last-pin.
Potential Side Effects
Signature side-effects: night sweats, insomnia, aggression, cardiovascular stress, “tren cough” at injection. Not hepatotoxic but raises creatinine. Cabergoline 0.25 mg 2×/week for prolactin. HDL crashes. Not for beginners or anyone cardiovascular-risk.
Cycle & Stacking Guide
Advanced cutting or recomp, 8–10 weeks. Standard stack: test 200–300 mg/week + tren ace 200–300 mg/week + masteron or winstrol. Not a first cycle. Monitor resting HR, BP, and sleep quality throughout.
Storage & Handling
Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.
Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead
19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.
We use cookies for essential site functionality and — with your consent — for analytics and marketing. You can accept all, reject non-essential, or configure. Privacy Policy
Reviews
There are no reviews yet.